Corealis Pharma will be attending CPHI Milan 2026, one of the world’s largest gatherings of the global pharmaceutical community, bringing together companies and professionals from across the pharma supply chain.

David Leroux-Petersen, CEO of Corealis Pharma, will be attending on behalf of Corealis and looks forward to connecting with pharmaceutical and biotechnology companies seeking experienced development and manufacturing partners for oral solid dose programs.

From pre-formulation and formulation development to analytical services, GMP clinical manufacturing, packaging, and clinical supply, Corealis provides integrated solutions designed to help sponsors move programs efficiently from early development toward the clinic and commercialization.

If you’ll be attending CPHI Milan, connect with David to discuss your development goals and explore how Corealis can support your program.